REGENXBIO(RGNX) - 2025 Q4 - Earnings Call Transcript

Regenxbio (NasdaqGS:RGNX) Q4 2025 Earnings call March 05, 2026 08:00 AM ET Company ParticipantsCurran Simpson - President and CEODaniel Connell - Account ManagerMitchell Chan - EVP and CFOPatrick Christmas II - Chief Legal OfficerSteve Pakola - Chief Medical OfficerConference Call ParticipantsAlec Stranahan - VP and Senior Equity Research AnalystAnnabel Samimy - Md and Senior Equity Research AnalystBrian Skorney - Md and Senior Research AnalystEduardo Martinez-Montes - Equity Research AnalystJudah Frommer - ...